BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33777735)

  • 41. Differential Expression and Prognostic Correlation of Immune Related Factors Between Right and Left Side Colorectal Cancer.
    Hu Y; Ding J; Wu C; Gao H; Ge M; Shao Q; Liu Y; Ye Q
    Front Oncol; 2022; 12():845765. PubMed ID: 35936748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alternative Splicing Events in Tumor Immune Infiltration in Colorectal Cancer.
    Shi JY; Bi YY; Yu BF; Wang QF; Teng D; Wu DN
    Front Oncol; 2021; 11():583547. PubMed ID: 33996533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between PPP2CA expression and colorectal cancer prognosis tumor marker prognostic study.
    Yong L; YuFeng Z; Guang B
    Int J Surg; 2018 Nov; 59():80-89. PubMed ID: 30296597
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integrative in silico and in vitro transcriptomics analysis revealed new lncRNAs related to intrinsic apoptotic genes in colorectal cancer.
    Akbari F; Peymani M; Salehzadeh A; Ghaedi K
    Cancer Cell Int; 2020 Nov; 20(1):546. PubMed ID: 33292233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer.
    Ye L; Zhang T; Kang Z; Guo G; Sun Y; Lin K; Huang Q; Shi X; Ni Z; Ding N; Zhao KN; Chang W; Wang J; Lin F; Xue X
    Front Immunol; 2019; 10():2368. PubMed ID: 31681276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
    Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
    J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comprehensive analysis of five long noncoding RNAs expression as competing endogenous RNAs in regulating hepatoma carcinoma.
    Lou X; Li J; Yu D; Wei YQ; Feng S; Sun JJ
    Cancer Med; 2019 Sep; 8(12):5735-5749. PubMed ID: 31392826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
    Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 50. LIMK1: A promising prognostic and immune infiltration indicator in colorectal cancer.
    Liu X; Song Q; Wang D; Liu Y; Zhang Z; Fu W
    Oncol Lett; 2022 Jul; 24(1):234. PubMed ID: 35720504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic implications of metabolism-associated gene signatures in colorectal cancer.
    Miao Y; Li Q; Wang J; Quan W; Li C; Yang Y; Mi D
    PeerJ; 2020; 8():e9847. PubMed ID: 32953273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma.
    Wang J; Yin X; Zhang YQ; Ji X
    Front Genet; 2021; 12():639254. PubMed ID: 33708243
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 54. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
    Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
    Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumour-Infiltrating Immune Cell-Based Subtyping and Signature Gene Analysis in Breast Cancer Based on Gene Expression Profiles.
    Jiang J; Pan W; Xu Y; Ni C; Xue D; Chen Z; Chen W; Huang J
    J Cancer; 2020; 11(6):1568-1583. PubMed ID: 32047563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An autophagy-related long non-coding RNA signature for glioma.
    Luan F; Chen W; Chen M; Yan J; Chen H; Yu H; Liu T; Mo L
    FEBS Open Bio; 2019 Apr; 9(4):653-667. PubMed ID: 30984540
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis.
    Ye LC; Ren L; Qiu JJ; Zhu DX; Chen T; Chang WJ; Lv SX; Xu J
    Tumour Biol; 2015 Nov; 36(11):8747-54. PubMed ID: 26050227
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
    Qi X; Qi C; Qin B; Kang X; Hu Y; Han W
    Front Oncol; 2020; 10():541330. PubMed ID: 33072571
    [No Abstract]   [Full Text] [Related]  

  • 59. Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma.
    Xu JZ; Gong C; Xie ZF; Zhao H
    Front Oncol; 2020; 10():593022. PubMed ID: 33585210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of Stage 4 and Stage 4s Neuroblastoma Identifies Autophagy-Related Gene and LncRNA Signatures Associated With Prognosis.
    Meng X; Li H; Fang E; Feng J; Zhao X
    Front Oncol; 2020; 10():1411. PubMed ID: 32974147
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.